Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Early antibiotic exposure, but not late exposure, negatively affects the clinical outcomes of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma
Related
- Real-world evidence for atezolizumab with bevacizumab for unresectable hepatocellular carcinoma: a multicentre UK Midlands cohort
- Curative Locoregional Therapy following Objective Response to Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
- Baseline Predictors, Prognostic Impact, and Risk Stratification of Early Progressive Disease on Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Study.
- Acute colonic variceal bleeding treated with coil-assisted retrograde transvenous obliteration following atezolizumab-bevacizumab therapy for advanced hepatocellular carcinoma: A case report.
- Prognostic Significance of Response Dynamics in Atezolizumab plus Bevacizumab-Treated Hepatocellular Carcinoma: A Multicenter Real-World Validation Study.
BibTeX
@article{kim2026early,
title = {{Early antibiotic exposure, but not late exposure, negatively affects the clinical outcomes of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma}},
author = {Aryoung Kim and Myung Ji Goh and Byeong Geun Song and Dong Hyun Sinn and Geum-Youn Gwak and Yong-Han Paik and Moon Seok Choi and Joon Hyeok Lee and Wonseok Kang},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-77233-x},
url = {https://www.nature.com/articles/s41598-026-77233-x},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Early antibiotic exposure, but not late exposure, negatively affects the clinical outcomes of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma
AU - Aryoung Kim
AU - Myung Ji Goh
AU - Byeong Geun Song
AU - Dong Hyun Sinn
AU - Geum-Youn Gwak
AU - Yong-Han Paik
AU - Moon Seok Choi
AU - Joon Hyeok Lee
AU - Wonseok Kang
PY - 2026
DA - 2026/10/21
JO - Scientific Reports
DO - 10.1038/s41598-026-77233-x
UR - https://www.nature.com/articles/s41598-026-77233-x
SN - 2045-2322
ER -